Skip to main content

Table 4 Comparison of laboratory findings among the four clusters

From: Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

 

Cluster 1

Cluster 2

Cluster 3

Cluster 4

p-value

Young healthy

Middle aged

Middle aged obese

Elderly

WBC, /μL

4854.2 ± 141

5530.2 ± 146.4

5531.3 ± 110

5553.9 ± 118.8

0.0003

Lymphocyte, %

28.9 ± 0.7

19.9 ± 0.8

22.9 ± 0.6

21.1 ± 0.6

< 0.0001

Lymphocyte, /μL

1317.6 ± 38.8

1146.1 ± 26

1105 ± 40.8

1048.8 ± 24.2

< 0.0001

Hb, g/dL

14.5 ± 0.1

14.2 ± 0.1

14.8 ± 0.1

12.9 ± 0.1

< 0.0001

PLT, × 104/μL

21.9 ± 0.5

19.8 ± 0.5

19.3 ± 0.4

19 ± 0.4

< 0.0001

Alb, g/dL

4.3 ± 0.03

3.8 ± 0.03

3.8 ± 0.02

3.5 ± 0.03

< 0.0001

TB, mg/dL

0.6 ± 0.03

0.7 ± 0.03

0.7 ± 0.02

0.6 ± 0.02

0.0104

ALP, U/L

154.5 ± 8.4

163.5 ± 8.6

178.2 ± 6.5

188.3 ± 6.9

0.0091

γGTP, U/L

41.5 ± 5.3

66.5 ± 5.5

92.3 ± 4.1

48.5 ± 4.4

< 0.0001

AST, U/L

26.6 ± 2

41.7 ± 2.1

45.2 ± 1.6

36 ± 1.7

< 0.0001

ALT, U/L

28.8 ± 2.1

33.9 ± 2.2

49.7 ± 1.6

26.6 ± 1.7

< 0.0001

BUN, mg/dL

10.8 ± 0.9

16.7 ± 0.9

15.9 ± 0.7

21.1 ± 0.7

< 0.0001

Cr, mg/dL

0.7 ± 0.1

1.3 ± 0.1

1.1 ± 0.1

1.2 ± 0.1

0.0006

LDH, U/L

193.8 ± 5.9

267.7 ± 6.1

272.3 ± 4.6

266 ± 4.9

< 0.0001

UA, mg/dL

4.7 ± 0.1

4.6 ± 0.1

5.2 ± 0.1

4.9 ± 0.1

< 0.0001

CK, U/L

93.9 ± 31.7

226.4 ± 32.8

152.1 ± 24.3

154 ± 26.2

0.0375

Na, mEq/L

140.1 ± 0.2

137.7 ± 0.2

137.8 ± 0.2

137.9 ± 0.2

< 0.0001

K, mEq/L

4 ± 0.03

4 ± 0.03

4 ± 0.02

4 ± 0.02

0.4417

Cl, mEq/L

103.5 ± 0.2

101.1 ± 0.3

101 ± 0.2

101.9 ± 0.2

< 0.0001

TroponinT, ng/mL

0.1 ± 1

1.2 ± 1.1

0.6 ± 0.8

2.4 ± 0.9

0.2919

BNP, pg/mL

7.5 ± 19.1

33.5 ± 15.7

31.4 ± 12.4

86.1 ± 13.8

0.0025

IgG, mg/dL

1197.4 ± 25.4

1184 ± 27.3

1208.2 ± 18.7

1231.6 ± 21

0.5306

IgA, mg/dL

231.9 ± 10.4

252.1 ± 11.4

287.2 ± 7.6

264.1 ± 8.5

0.0002

IgM, mg/dL

108.5 ± 4.6

82.5 ± 5

87.5 ± 3.3

85 ± 3.8

0.0001

C3, mg/dL

120.9 ± 4.1

123.4 ± 3.8

138.8 ± 2.5

111.7 ± 3.1

< 0.0001

C4, mg/dL

34.5 ± 1.9

39.9 ± 1.8

43.4 ± 1.2

34.7 ± 1.4

< 0.0001

CH50, U/mL

56.8 ± 5

73.2 ± 5.3

75.8 ± 3.2

63.8 ± 3.2

0.0053

Ferritin, ng/mL

240.7 ± 33.4

533.3 ± 35.1

655.4 ± 25.8

412.7 ± 28.6

< 0.0001

TG, mg/dL

115.5 ± 10.8

114.6 ± 11.1

159.3 ± 7.6

108 ± 8.5

< 0.0001

KL-6, U/mL

199.3 ± 16.1

273.4 ± 16.7

307.1 ± 12.4

356.2 ± 13.3

< 0.0001

HbA1c, %

5.5 ± 0.1

6.3 ± 0.1

6.7 ± 0.1

6.3 ± 0.1

< 0.0001

APTT, sec

33.6 ± 0.6

34.5 ± 0.6

34.2 ± 0.4

36.1 ± 0.5

0.0019

PT-INR

1 ± 0.01

1 ± 0.01

1 ± 0.01

1.1 ± 0.01

0.0061

Fibrinogen, mg/dL

363.7 ± 9.7

514.9 ± 10.1

514.6 ± 7.2

475.8 ± 7.8

< 0.0001

d-dimer, μg/mL

0.8 ± 0.4

1.7 ± 0.4

1.5 ± 0.3

2.8 ± 0.3

< 0.0001

Procalcitonin, ng/mL

0.1 ± 0.1

0.3 ± 0.1

0.1 ± 0.1

0.3 ± 0.1

0.0835

CRP, mg/dL

1.1 ± 0.3

5 ± 0.3

5 ± 0.2

4.7 ± 0.2

< 0.0001

  1. Data are shown as mean ± SD. Data were compared among groups using analysis of variance (ANOVA)
  2. WBC, white blood cell; Hb, hemoglobin; PLT, platelet; Alb, albumin; TB, total bilirubin; ALP, alkaline phosphatase; γGTP, γ-glutamyl transpeptidase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; LDH, lactate dehydrogenase; UA, uric acid; CK, creatinine kinase; Na, sodium; K, potassium; Cl, chlorine; BNP, brain natriuretic peptide; TG, triglyceride; KL-6, Krebs von den Lungen-6; APTT, activated partial thromboplastin time; PT-INR, prothrombin time-international normalized ratio; CRP, C-reactive protein